---
title: "Blueprint Technologies partnered with Superblocks for faster enterprise app development and AI innovation. (Characters: 97)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/274679730.md"
description: "Today, in Bellevue, Washington, Blueprint Technologies unveiled a new partnership with Superblocks, an AI platform specializing in constructing secure internal applications. This collaboration aims to leverage Blueprint's expertise in data intelligence and cloud cost optimization alongside Superblocks' advanced AI technology. The partnership is projected to enhance the efficiency and security of internal applications for businesses, demonstrating a strategic move by both companies."
datetime: "2026-02-03T15:05:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/274679730.md)
  - [en](https://longbridge.com/en/news/274679730.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/274679730.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/274679730.md) | [繁體中文](https://longbridge.com/zh-HK/news/274679730.md)


# Blueprint Technologies partnered with Superblocks for faster enterprise app development and AI innovation. (Characters: 97)

Today, in Bellevue, Washington, Blueprint Technologies unveiled a new partnership with Superblocks, an AI platform specializing in constructing secure internal applications. This collaboration aims to leverage Blueprint's expertise in data intelligence and cloud cost optimization alongside Superblocks' advanced AI technology. The partnership is projected to enhance the efficiency and security of internal applications for businesses, demonstrating a strategic move by both companies.

### Related Stocks

- [Blueprint Medicines Corporation (BPMC.US)](https://longbridge.com/en/quote/BPMC.US.md)

## Related News & Research

- [What to Expect from ADC Therapeutics's Earnings](https://longbridge.com/en/news/278420347.md)
- [Vertex's kidney disease drug meets main goal in late-stage trial](https://longbridge.com/en/news/278442392.md)
- [Why investors aren’t fleeing to safe-haven stocks](https://longbridge.com/en/news/278857323.md)
- [Should Teradyne’s AI-Driven Test Surge and 44% Revenue Jump Require Action From Teradyne (TER) Investors?](https://longbridge.com/en/news/278739518.md)
- [Swiss National Bank Trims Stock Position in Tyler Technologies, Inc. $TYL](https://longbridge.com/en/news/278877713.md)